Articles for Bharat Biotech

Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine
3 months, 1 week ago

Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine

Hindustan Times  

Hyderabad-based Bharat Biotech on Wednesday announced its collaboration with US-based Alopexx Inc for development and commercialisation of the latter’s broad-spectrum anti-microbial vaccine in India and other low-income countries, which experts feel could be a game-changer in tackling the growing anti-microbial resistance threat. This collaboration aligns with our mission to provide safe, affordable, and high-quality vaccines to combat infectious diseases globally,” …

Vaccines Resistance Vaccine Infections Antimicrobial Bharat Biotech
Bharat Biotech unveils oral cholera vaccine developed in partnership with Hilleman Labs
3 months, 3 weeks ago

Bharat Biotech unveils oral cholera vaccine developed in partnership with Hilleman Labs

The Hindu  

Vaccine maker Bharat Biotech International Ltd on Tuesday launched Hillchol, a novel single-strain oral cholera vaccine it has developed under licence from Hilleman Laboratories. Bharat Biotech it has established large-scale manufacturing facilities in Hyderabad and Bhubaneswar with a capacity to produce up to 200 million doses of Hillchol, founder Krishna Ella and co-founder Suchitra Ella told media after the launch. …

India Hyderabad Bhubaneswar Bharat Vaccine Bharat Biotech Cholera
ICMR got ₹172 cr. from Bharat Biotech for Covaxin: Nadda
4 months, 3 weeks ago

ICMR got ₹172 cr. from Bharat Biotech for Covaxin: Nadda

The Hindu  

The Indian Council of Medical Research has received ₹172 crore as royalty from Bharat Biotech International Limited for jointly developing Covaxin, an indigenously developed vaccine for COVID-19, Union Health Minister J.P. Nadda said, during Question Hour in the Lok Sabha on Friday. Covaxin was jointly developed by ICMR, National Institute of Virology, and Bharat Biotech International Ltd, in two phases. …

India Nadda Niv Bharat Icmr Bharat Biotech Biotech
Bharat Biotech corrects Covaxin patent to include ICMR, NIV after govt objections: Health Minister
4 months, 3 weeks ago

Bharat Biotech corrects Covaxin patent to include ICMR, NIV after govt objections: Health Minister

New Indian Express  

NEW DELHI: Union health minister J P Nadda on Friday said that Bharat Biotech initially did not mention ICMR and NIV as co-inventors in the patent application for Covaxin and the application was corrected after objections were raised by the government. Covaxin, which was widely used as a Covid vaccine, was jointly developed by the Indian Council of Medical Research, …

Nadda Niv Bharat Icmr Bharat Biotech Biotech Corrects Covaxin
The right way to counter a poor Covaxin safety study
4 months, 3 weeks ago

The right way to counter a poor Covaxin safety study

The Hindu  

It took all of five days for the Indian Council of Medical Research to strongly criticise the poor design of the long-term safety study of Covaxin by researchers from the Banaras Hindu University, Varanasi. A publication failure that is glaring Three years after the interim data were posted as a preprint, Bharat Biotech and ICMR are yet to publish any …

Trial Study Vaccine Participants Clinical Icmr Bhu
Erred in not crediting ICMR as co-inventor of Covaxin, says Bharat Biotech
6 months ago

Erred in not crediting ICMR as co-inventor of Covaxin, says Bharat Biotech

The Hindu  

Hyderabad-based Bharat Biotech International Limited and manufacturer of Covaxin, India’s first indigenous Covid-19 vaccine, said it had made an “inadvertent mistake” in not including scientists from the Indian Council of Medical Research as ‘co-inventors’ in patent applications filed in India and abroad to protect the intellectual property rights around the vaccine. Bharat Biotech said it did not have “access” to …

India Patent Hindu Bharat Vaccine Icmr Bharat Biotech
Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR
6 months ago

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR

The Hindu  

India’s first indigenously developed coronavirus vaccine, Covaxin, was a joint collaboration between the Indian Council of Medical Research and the Hyderabad-based Bharat Biotech International Limited with intellectual property rights jointly shared between the two organisations. The Minister’s statement said the ICMR would provide a “well characterised” virus strain for vaccine development, the BBIL would develop the final vaccine formulation and, …

India Development Intellectual Property Patent Hindu Niv Mou
Why COVID vaccine safety needs scrutiny | Explained
6 months, 3 weeks ago

Why COVID vaccine safety needs scrutiny | Explained

The Hindu  

The story so far: The Indian Council for Medical Research issued a letter to the researchers of Banaras Hindu University last week, countering their study on the side effects of India’s indigenous vaccine for COVID — Covaxin. The one-year observational, follow-up study titled ‘Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: Findings from a one-year prospective …

Safety Research Paper Study Letter Vaccine Researchers
ICMR distances itself from safety study on Covaxin
7 months ago

ICMR distances itself from safety study on Covaxin

Hindustan Times  

The country’s apex biomedical research regulator, the Indian Council of Medical Research, has distanced itself from a Banaras Hindu University study that raised concerns on safety of Bharat Biotech’s Covid vaccine, Covaxin, and threatened legal action against the study’s authors for acknowledging ICMR’s support for a poorly designed study without its consent. ICMR chief Rajiv Bahl has formally written to …

Safety Research Events Medical Research Paper Study Vaccine
Covaxin side effects: Amid concerns of adverse events, should Covaxin takers be worried?
7 months ago

Covaxin side effects: Amid concerns of adverse events, should Covaxin takers be worried?

Hindustan Times  

A team of researchers at BHU in a one-year follow-up study found out that nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI. Serious AESI, including stroke and Guillain-Barre syndrome, were reported in around one per cent of individuals as per the study. Serious AESI, including stroke and Guillain-Barre …

Events Patients Stroke Cent Study Vaccine Gbs
Over 30% of Covaxin takers faced nervous system disorders, menstrual abnormalities: Study
7 months, 1 week ago

Over 30% of Covaxin takers faced nervous system disorders, menstrual abnormalities: Study

Live Mint  

A study conducted by a team of researchers at the Banaras Hindu University states that nearly 30 per cent of the 926 recipients of Bharat Biotech's Covaxin reported experiencing “adverse events of special interest” or AESI. Among the adolescents, the most common AESIs were: Skin and subcutaneous disorders, general disorders, and nervous system disorders. New-onset skin and subcutaneous disorders, general …

Cent Study Bharat Biotech General Disorders Nervous System Disorders Disorders General
BHU study: Over 30 per cent of Covaxin recipients report adverse events
7 months, 1 week ago

BHU study: Over 30 per cent of Covaxin recipients report adverse events

India TV News  

A recent study conducted by researchers at Banaras Hindu University revealed that over 30% of individuals who received Bharat Biotech's Covaxin reported adverse events. The one-year follow-up study, encompassing 926 participants, shed light on the long-term safety of the BBV152 vaccine, with serious adverse events of special interest such as stroke and Guillain-Barre syndrome reported in one per cent of …

Bharat Biotech Bhu Study Covaxin Vaccine
‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times  

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

India Safety Covid Bharat Vaccine Bharat Biotech Biotech
Bharat Biotech promoter Krishna Ella is new President of IVMA
7 months, 3 weeks ago

Bharat Biotech promoter Krishna Ella is new President of IVMA

Deccan Chronicle  

Hyderabad: The Indian Vaccine Manufacturers Association has announced Krishna M Ella, Co-Founder, Executive Chairman of Bharat Biotech as the association's new President for a two-year period from April 2024. "Vaccines are the vital pillar of global health, and the IVMA mission is to ensure that every individual, regardless of where they live, has access to life-saving immunizations," Ella said adding …

India Ella Bharat Bharat Biotech Ivma
India eyes to increase oral polio vaccine supply
7 months, 4 weeks ago

India eyes to increase oral polio vaccine supply

Live Mint  

New Delhi: The Centre is looking to increase the manufacturing capacity of oral polio vaccine, said Union Health and Family Welfare Secretary Apurva Chander. "An agreement has been signed under which Bharat Biotech will procure drug substances for manufacturing oral polio vaccines to be supplied within India and globally. With this partnership, the capacity of BBIL to manufacture Oral Polio …

Netherlands Polio Production Vaccines Bharat Polio Vaccine Bharat Biotech
Bharat Biotech, Bilthoven Biologicals Announce Collaboration To Produce and Supply Oral Polio Vaccines
8 months, 3 weeks ago

Bharat Biotech, Bilthoven Biologicals Announce Collaboration To Produce and Supply Oral Polio Vaccines

Deccan Chronicle  

Hyderabad: Vaccine maker Bharat Biotech and Bilthoven Biologicals BV, a wholly owned subsidiary of Serum Institute of India Private Limited, based in the Netherlands, announced a collaboration to strengthen the production and supply security of oral polio vaccines. A requisite agreement has been signed wherein Bharat Biotech will procure drug substances for the production of oral polio vaccines to be …

India Polio Vaccines Bharat Bharat Biotech Biotech Polio Vaccines
Bharat Biotech starts TB vaccine’s trials in adults
8 months, 4 weeks ago

Bharat Biotech starts TB vaccine’s trials in adults

Hindustan Times  

Bharat Biotech has begun clinical trials of the Spanish anti-tuberculosis vaccine among adults in India, the Hydreabad-based pharmaceutical company announced on Sunday. Tuberculosis, which is transmitted through the respiratory tract, kills at least 1.6 million people and infects at least 10 million worldwide each year “The trials are carried out by Bharat Biotech in close collaboration with Biofabri,” the company …

India Trial Trials Clinical Trials Phase Bharat Adults
How India’s Vaccine Industry Will Save Millions of Children in Africa - News18
1 year, 2 months ago

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18

News 18  

On 2 October 2023, when India celebrated both Gandhi and Lal Bahadur Shastri Jayanti, there was one more reason to celebrate this year. In April 2023, almost coinciding with World Malaria Day, the West African nation Ghana approved the malaria vaccine R21, even before it was approved by the WHO. The vaccine R21 is developed at the University of Oxford …

India Children Africa Nigeria Malaria Ghana Vaccines
Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality
1 year, 6 months ago

Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality

The Hindu  

Flagged by the Central Drugs Standard Control Organisation as “not of standard quality’’, Hyderabad-based Bharat Biotech on June 8 confirmed that it had recalled a batch of its typhoid vaccine. “Bharat Biotech has initiated a recall of TYPBAR batch 54A22001A and communicated the same to the distribution chain,” a Bharat Biotech statement said. According to an alert by CDSCO, the …

Hyderabad Cdsco Bharat Vaccine Bharat Biotech Biotech Standard Quality
India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 6 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

Health India Indian Vaccines G20 Covid Niv
Behind the ‘dearth’ of rabies vaccine in India
1 year, 7 months ago

Behind the ‘dearth’ of rabies vaccine in India

The Hindu  

Every year from November to March, when the weather improves across most of India, and people begin to spill out of their homes, the mating season for dogs begins. At times, demands from States are delayed by many months making it difficult for us to cater to the demand on time,” a senior executive working closely with one of rabies …

States Indian Market Demand Million Manufacturers Vaccine Rabies
Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India
1 year, 10 months ago

Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India

Live Mint  

The world's first intranasal heterologous booster dose has begun to be dispatched by Bharat Biotech to hospitals, Executive Chairman Dr. Krishna Ella announced on February 5. He discussed the delivery of vaccines under the bilateral agreement between the Ella Foundation and the UW-Madison Global Health Institute for the establishment of the first-ever UW-Madison One Health Center in India for improving …

India Bharat Biotech Big Thing Incovacc Dispatching Nasal Vaccine Nasal Vaccine Dispatching Nasal
COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 10 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Health India Research Ella Bharat Vaccine Bharat Biotech
India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

India Covid Vaccine Bharat Biotech Incovacc Ncovacc Biotech Nasal